Sam Z Thalji

6PUBLICATIONS
34CO-AUTHORS
Molecular targetsNeonatologyPredictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 24, 2025
Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.

Mandana Kamgar, G Aaron Hobbes, Raven Davidson

|Dec 23, 2023
Associations between Hospital Setting and Outcomes after Pediatric Appendectomy.

Anshul Bhatnagar, Sean Mackman, Kyle J Van Arendonk

|Mar 24, 2023
Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity.

Sam Z Thalji, Mohammed Aldakkak, Kathleen K Christians

|Dec 08, 2022
Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative.

Sam Z Thalji, Cecilia G Ethun, Susan Tsai

|Mar 14, 2020
Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative.

Sam Z Thalji, Susan Tsai, T Clark Gamblin

Pageof 1

Frequent Collaborators

3 joint publications

Callisia N Clarke

3 joint publications

Susan Tsai

2 joint publications

T Clark Gamblin

2 joint publications

Kenneth Cardona